Description
Asia-Pacific Lipid POCT Market, By Type (Instruments, Consumables and Kits), Application (Hyperlipidemia, Hypertriglyceridemia, Hyperlipoproteinemia, Familial hypercholesterolemia, Tangier Disease, Others), Mode (Prescription-Based Testing, OTC-Based Testing), Brand (Roche Reflotron, Roche Cobas B 101, Alere Cholestech LDX, Alere Afinion, Samsung Labgeo, PTS Cardiochek, Others), Platform (Lateral Flow Assays (Immunochromatography Tests), Molecular Diagnostics, Immunoassays, Dipsticks, Microfluidics), End User (Hospitals, Professional Diagnostic Centers, Home Care, Research Laboratories, Other End Users), Distribution Channel (Direct Tender, Retail Sales), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific) Industry Trends and Forecast to 2028.
Depending on client’s requirements, business and product information has brought together via this Asia-Pacific Lipid POCT Market report that ultimately helps businesses take better decisions. This market research report is a persuaded solution to have top-quality market research data that suits best to the business needs. Whether it is about refining a business plan, preparing a presentation for an important client, or giving recommendations to an executive, this market report helps a lot. The quality and transparency maintained in this Asia-Pacific Lipid POCT Market report makes gain the trust and reliance of member companies and customers.
ASIA-PACIFIC LIPID POCT MARKET ANALYSIS AND INSIGHT
- The lipid POCT market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.7% in the forecast period of 2021 to 2028 and is expected to reach USD 222.28 million by 2028. The rise in the number of chronic infections has led to people opting for point-of-care kits and products for testing and therefore this will drive the growth of the lipid POCT market.
- Market research analysis accomplished in this Asia-Pacific Lipid POCT market report hopefully lends a hand to businesses for the strategy planning related to production, costing, inventory, purchasing and marketing. The global market research report deals with a number of industry and market parameters including latest trends, market segmentation, new market entry, industry forecasting, target market analysis, future directions, opportunity identification, strategic analysis, insights and innovation. Asia-Pacific Lipid POCT market research report also serves the businesses to make enhanced decisions, deal with marketing of goods or services, and accomplish better profitability by prioritizing market goals. Customer requirement has been kept into focus while preparing this professional and in-depth Asia-Pacific Lipid POCT market research report.
Get the sample copy of Report here: https://www.databridgemarketresearch.com/reports/asia-pacific-lipid-poct-market
ASIA-PACIFIC LIPID POCT MARKET SEGMENTATION
- On the basis of type, the lipid POCT market is segmented into instruments, consumables and kits. In 2021, the instruments segment in the lipid POCT market is expected to grow due to changing lifestyles and increasing chronic diseases and a lack of awareness of over-the-counter POCT devices.
- On the basis of application, the lipid POCT market is segmented into hyperlipidemia, hypertriglyceridemia, hyperlipoproteinemia, tangier disease, familial hypercholesterolemia and others. In 2021, the hyperlipidemia segment in the lipid POCT market is expected to dominate because of the rising geriatric population and unhealthy lifestyle.
- On the basis of mode, the lipid POCT market is segmented into OTC-based testing and prescription-based testing. In 2021, the prescription-based test segment in the lipid POCT market is expected to dominate because of high preference of point of care lipid testing been recommended for lipid profiling in hospitals and skilled laboratory professionals.
- On the basis of brand, the lipid POCT market is segmented into roche reflotron, roche cobas B 101, alere cholestech LDX, alere afinion, samsung labgeo, PTS cardiochek and others. In 2021, the roche reflectron segment is expected to dominate in lipid POCT market due to their advanced technology over point of care devices.
- On the basis of platform, the lipid POCT market is segmented into lateral flow assays (immunochromatography tests), dipsticks, microfluidics, molecular diagnostics and immunoassays. In 2021, the lateral flow assays (immunochromatography tests) segment in the lipid POCT market is expected to grow due to advanced technologies and inventions.
- On the basis of end user, the lipid POCT market is segmented into hospitals, professional diagnostic centers, home care, research laboratories and other end users. In 2021, the hospitals segment in the lipid POCT market is expected to grow due to growing patient emphasis on diagnosis operations.
- On the basis of distribution channel, the lipid POCT market is segmented into direct tender and retail sales. In 2021, direct tender segment in the lipid POCT market is expected to grow due to the increased demand for advanced technologies and testing requirements in medical care for operations and diagnosis.
ASIA-PACIFIC LIPID POCT MARKET COUNTRY LEVEL ANALYSIS
- Asia-Pacific lipid POCT market is analysed and market size information is provided by the country, type, application, mode, brand, platform, end user and distribution channel as referenced above.
- The countries covered in the Asia-Pacific lipid POCT market report are the Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific.
ASIA-PACIFIC LIPID POCT MARKET SHARE ANALYSIS
The lipid POCT market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Asia-Pacific lipid POCT market.
KEY PLAYERS LIPID POCT MARKET
- Abbott
- F. Hoffmann-La Roche Ltd.
- SD Biosensor, INC.
- PTS Diagnostics
- Trinity Biotech
- AMD SOLUTIONS
Get Full Access of Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-lipid-poct-market
MAJOR TOC OF THE REPORT
- INTRODUCTION
- MARKET SEGMENTATION
- EXECUTIVE SUMMARY
- PREMIUM INSIGHTS
- MARKET OVERVIEW
- QUESTIONNAIRE
- RELATED REPORTS
Get TOC Details: https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-lipid-poct-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com